Joachim Fruebis

Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice.

D. Steinberg, R. Tangirala, W. Palinski, 1998, Journal of lipid research.

Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors.

J. Witztum, S. Parthasarathy, J. Fruebis, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis.

W. Palinski, J. Fruebis, M. Silvestre, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Evidence for a concerted reaction between lipid hydroperoxides and polypeptides.

D. Steinberg, S. Parthasarathy, J. Fruebis, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits.

T. Carew, W. Palinski, J. Fruebis, 1995, Atherosclerosis.

A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits.

T. Carew, D. Steinberg, J. Fruebis, 1994, The Journal of clinical investigation.